Avapro, Hyzaar Paragraph IV Filings
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Merck's antihypertensive agent Hyzaar (losartan/ hydrochlorothiazide) was filed May 24, according to FDA's July 15 updated list of Paragraph IV filings